Site Selection and Performance in Clinical Trials: The Need for Better Understanding

被引：2
作者：
McMurray, John J. V. [1 ]
机构：
[1] BHF Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland
来源：
CIRCULATION-HEART FAILURE | 2016年 / 9卷 / 09期
关键词：
Editorials; dyspnea; enrollment; heart failure; randomized controlled trial; site; HEART-FAILURE; VASOPRESSIN ANTAGONISM; EVEREST EFFICACY; END-POINTS; OUTCOMES; MANAGEMENT;
D O I：
10.1161/CIRCHEARTFAILURE.116.003490
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Distinguishing Clinical and Research Risks in Pragmatic Clinical Trials: The Need for Further Stakeholder Engagement
    Wilfond, Benjamin S.
    Turk, Sinem Toraman
    Kraft, Stephanie A.
    Weiss, Elliott M.
    Tarr, Philip I. I.
    Schnadower, David
    Freedman, Stephen B.
    AMERICAN JOURNAL OF BIOETHICS, 2023, 23 (08) : 39 - 42
  • [42] Influence of Arterial Access Site Selection on Outcomes in Primary Percutaneous Coronary Intervention Are the Results of Randomized Trials Achievable in Clinical Practice?
    Mamas, Mamas A.
    Ratib, Karim
    Routledge, Helen
    Neyses, Ludwig
    Fraser, Douglas G.
    de Belder, Mark
    Ludman, Peter F.
    Nolan, Jim
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (07) : 698 - 706
  • [43] A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach
    Pang, Peter S.
    Cleland, John G. F.
    Teerlink, John R.
    Collins, Sean P.
    Lindsell, Christopher J.
    Sopko, George
    Peacock, W. Frank
    Fonarow, Gregg C.
    Aldeen, Amer Z.
    Kirk, J. Douglas
    Storrow, Alan B.
    Tavares, Miguel
    Mebazaa, Alexandre
    Roland, Edmond
    Massie, Barry M.
    Maisel, Alan S.
    Komajda, Michel
    Filippatos, Gerasimos
    Gheorghiade, Mihai
    EUROPEAN HEART JOURNAL, 2008, 29 (06) : 816 - 824
  • [44] Better Regulation of Industry-Sponsored Clinical Trials Is Long Overdue
    Wynia, Matthew
    Boren, David
    JOURNAL OF LAW MEDICINE & ETHICS, 2009, 37 (03) : 410 - +
  • [45] Heart Failure Clinical Trials in East and Southeast Asia Understanding the Importance and Defining the Next Steps
    Mentz, Robert J.
    Roessig, Lothar
    Greenberg, Barry H.
    Sato, Naoki
    Shinagawa, Kaori
    Yeo, Daniel
    Kwok, Bernard W. K.
    Reyes, Eugenio B.
    Krum, Henry
    Pieske, Burkert
    Greene, Stephen J.
    Ambrosy, Andrew P.
    Kelly, Jacob P.
    Zannad, Faiez
    Pitt, Bertram
    Lam, Carolyn S. P.
    JACC-HEART FAILURE, 2016, 4 (06) : 419 - 427
  • [46] Better than what? Comparisons in low back pain clinical trials
    Travers, Mervyn J.
    Bagg, Matthew K.
    Gibson, William
    O'Sullivan, Kieran
    Palsson, Thorvaldur Skuli
    BRITISH JOURNAL OF SPORTS MEDICINE, 2019, 53 (14) : 847 - +
  • [47] Cancer vaccines: What do we need to measure in clinical trials?
    Kudrin, Alex
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3236 - 3240
  • [48] Preventive implantable cardioverter defibrillator therapy in contemporary clinical practice: need for more stringent selection criteria
    Deckers, Jaap W.
    Arshi, Banafsheh
    van den Berge, Jan C.
    Constantinescu, Alina A.
    ESC HEART FAILURE, 2021, 8 (05): : 3656 - 3662
  • [49] Are cancer patients better off if they participate in clinical trials? A mixed methods study
    Nielsen, Zandra Engelbak
    Eriksson, Stefan
    Harslof, Laurine Bente Schram
    Petri, Suzanne
    Helgesson, Gert
    Mangset, Margrete
    Godskesen, Tove E.
    BMC CANCER, 2020, 20 (01)
  • [50] Are cancer patients better off if they participate in clinical trials? A mixed methods study
    Zandra Engelbak Nielsen
    Stefan Eriksson
    Laurine Bente Schram Harsløf
    Suzanne Petri
    Gert Helgesson
    Margrete Mangset
    Tove E. Godskesen
    BMC Cancer, 20
12345